Records containing: Raynaud Phenomenon
This is the wording recorded or indexed by the source. An agency index term is not necessarily an authorised indication. Co-listed drug names are not linked to this term as a treatment relationship.
Follow recorded terms in Drug Alerts for Android. Free includes unlimited local condition follows and an on-open recent-record watchlist. Plus adds no ads and personal organization tools.
All
FDA submission records
EMA medicine records
ClinicalTrials.gov record updates
ClinicalTrials.gov records with results posted
-
CLINICAL_TRIALS study results posted · 2026-07-29Double Blind RCT to Evaluate the Effect of Botulinum Toxin in Raynaud Phenomenon
-
CLINICAL_TRIALS study record update · 2025-07-15Potential Benefit for Non Invasive Vagus Nerve Stimulation (nVNS) Using GammaCore in the Treatment of Raynaud's Phenomena.
-
CLINICAL_TRIALS study record update · 2025-04-03NIHR i4i 2: Early Diagnosis of Systemic Sclerosis in the General Rheumatology Clinic - Pilot Image Acquisition Study
-
CLINICAL_TRIALS study record update · 2025-04-02An Open-Label Study of the Apollo Device for Fatigue in Systemic Sclerosis
-
CLINICAL_TRIALS study record update · 2025-02-12Double Blind RCT to Evaluate the Effect of Botulinum Toxin in Raynaud Phenomenon
- Organize your saved records without ads with Plus.
-
CLINICAL_TRIALS study record update · 2023-12-06Development of an Application for the Monitoring and Evaluation of Raynaud's Phenomenon
-
CLINICAL_TRIALS study record update · 2023-05-18A Phase 2, Single-center, Randomised, Double-blind, Placebo-controlled, Cross-over Cold Challenge Study Investigating the Effect of C21 on Cold-induced Vasoconstriction in Subjects With Raynaud's Phenomenon (RP) Secondary to Systemic Sclerosis (SSc)
-
CLINICAL_TRIALS study record update · 2023-01-06Phototherapy For Treatment Of Raynaud's Phenomenon
-
CLINICAL_TRIALS study record update · 2022-03-23A Randomized Controlled Prospective Single-center Feasibility Study of Rheopheresis for Raynaud's Syndrome and Digital Ulcers in Systemic Sclerosis
-
CLINICAL_TRIALS study record update · 2021-07-20Prospective Validation of 5 Items in Nailfold Dermoscopy to Predict a Normal Capillaroscopy in Raynaud's Phenomenon
-
CLINICAL_TRIALS study record update · 2021-06-30The Effect of Abobotulinum Toxin A on the Symptoms of Raynaud's Phenomenon, a Double-Blind Randomized Placebo-Controlled Trial
-
CLINICAL_TRIALS study record update · 2021-05-14Nutritional Strategies to Increase Nitric Oxide Signaling in Raynaud's Phenomenon
-
CLINICAL_TRIALS study record update · 2020-11-09Effectiveness of an Intervention Program With Electric Stimulation Therapy in Patients With Raynaud's Phenomenon: a Randomized Clinical Trial
-
CLINICAL_TRIALS study record update · 2020-02-10Beet the Cold: The Effect of Inorganic Nitrate Supplementation on Peripheral Blood Flow and Pain in Individuals With Raynaud's Phenomenon. A Pilot, Double-blind, Placebo Controlled, Randomised Crossover Trial
-
CLINICAL_TRIALS study record update · 2019-07-10Follow-up of Single-port Thoracoscopic Sympathicotomy in Patients With Raynaud's Phenomenon
-
CLINICAL_TRIALS study record update · 2019-06-03Localized Effects of Photobiomodulation and Exogenous Nitric Oxide on CREST Patients Calcinosis Cutis & Raynaud Phenomenon
-
CLINICAL_TRIALS study record update · 2019-02-28RaynAUT - Thermography and the Autonomic Nervous System in Raynaud's Phenomenon - Investigation of the Autonomic Nervous System in Patients With Raynaud's Phenomenon, Glaucoma, and Autonomic Neuropathy.
-
CLINICAL_TRIALS study record update · 2018-09-20A Multicenter Observational Pilot Study on the Use of Tadalafil Delivra Cream in the Treatment of Raynaud's Phenomenon and Pain Associated With Digital Ulcers
-
CLINICAL_TRIALS study record update · 2016-12-05Effect of Sildenafil on the Microcirculatory Blood Flow and on the Endothelial Progenitor Cells in Patients With Systemic Sclerosis: a Randomized, Double-blind, Placebo-controlled Clinical Trial
-
CLINICAL_TRIALS study record update · 2012-12-11Comparison of Phosphodiesterase-5 Inhibitor and Calcium Channel Inhibitor for the Treatment of Secondary Raynaud Phenomenon, Double Blind, Randomized, Cross-over Trial